Vincerx Pharma, Inc. (NASDAQ:VINC – Get Free Report) saw a significant decrease in short interest in May. As of May 15th, there was short interest totalling 567,500 shares, a decrease of 44.9% from the April 30th total of 1,030,000 shares. Based on an average trading volume of 927,300 shares, the short-interest ratio is presently 0.6 […]
Cantor Fitzgerald restated their overweight rating on shares of Vincerx Pharma (NASDAQ:VINC – Free Report) in a report released on Tuesday morning, Benzinga reports. Vincerx Pharma Price Performance VINC opened at $1.00 on Tuesday. Vincerx Pharma has a one year low of $0.61 and a one year high of $9.37. The company’s 50 day simple […]
Cantor Fitzgerald Reaffirms Overweight Rating for Vincerx Pharma (NASDAQ:VINC) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Vincerx Pharma, Inc. (NASDAQ:VINC – Free Report) – Analysts at Cantor Fitzgerald boosted their FY2024 EPS estimates for shares of Vincerx Pharma in a research report issued to clients and investors on Monday, April 1st. Cantor Fitzgerald analyst L. Watsek now forecasts that the company will post earnings of ($0.63) per share for the year, […]
Vincerx Pharma (NASDAQ:VINC) Receives Overweight Rating from Cantor Fitzgerald theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.